These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29016347)

  • 21. Treatment of anorexia with megestrol acetate.
    Tchekmedyian NS
    Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
    Cabeza C; Corsi O; Pérez-Cruz P
    Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
    Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG
    J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated anorexia and cachexia. Implications for drug therapy.
    Loprinzi CL; Goldberg RM; Burnham NL
    Drugs; 1992 Apr; 43(4):499-506. PubMed ID: 1377116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new horizon of herbal medicines in anorexia-cachexia syndrome.
    Inui A
    Curr Pharm Des; 2012; 18(31):4747-8. PubMed ID: 22950447
    [No Abstract]   [Full Text] [Related]  

  • 27. North Central Cancer Treatment Group (NCCTG).
    Loprinzi CL
    J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472
    [No Abstract]   [Full Text] [Related]  

  • 28. Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients?
    Jatoi A; Loprinzi CL; Sloan J; Goldberg RM
    J Natl Cancer Inst; 2000 Feb; 92(4):290-1. PubMed ID: 10675368
    [No Abstract]   [Full Text] [Related]  

  • 29. IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment.
    Chowdhury IH; Rahman S; Afroze YJ; Shovah ST
    Pharmacol Res; 2024 May; 203():107129. PubMed ID: 38461961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 fatty acids improve appetite in cancer anorexia, but tumor resecting restores it.
    Goncalves CG; Ramos EJ; Romanova IV; Suzuki S; Chen C; Meguid MM
    Surgery; 2006 Feb; 139(2):202-8. PubMed ID: 16455329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
    Reuter SE; Martin JH
    Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress and wasting in cancer.
    Laviano A; Meguid MM; Preziosa I; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):449-56. PubMed ID: 17563463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anorexia and cachexia in advanced cancer patients.
    Vigano A; Watanabe S; Bruera E
    Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cancer anorexia-cachexia syndrome.
    Nelson KA; Walsh D; Sheehan FA
    J Clin Oncol; 1994 Jan; 12(1):213-25. PubMed ID: 8270980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
    Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
    Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalidomide: dual benefits in palliative medicine and oncology.
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(5):347-51. PubMed ID: 11565189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General metabolic abnormalities in cancer patients: anorexia and cachexia.
    Holroyde CP; Reichard GA
    Surg Clin North Am; 1986 Oct; 66(5):947-56. PubMed ID: 3532380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide in the treatment of cancer cachexia.
    Tassinari D; Santelmo C; Tombesi P; Sartori S
    J Palliat Care; 2008; 24(3):187-9. PubMed ID: 18942570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.